Latest Health News

THURSDAY, Oct. 8, 2020 (HealthDay News) -- After administering clot-busting drugs to treat a stroke, using blood pressure cuffs to squeeze each arm might aid recovery, a new, small Chinese study suggests. In the technique -- called remote ischemic post-conditioning -- the flow of oxygen-rich blood is repeatedly interrupted and restored using blood pressure cuffs on the arms. Earlier studies have found that the technique may prevent tissue damage by helping the body handle changes in blood flow and the damage that may occur from a stroke, researchers say. "The findings show a promising future prospect of remote ischemic post-conditioning and have important clinical implications," said researcher Dr. Guo-liang Li, of First Affiliated Hospital of Xi'an and Jiaotong University in...

THURSDAY, Oct. 8, 2020 (HealthDay News) -- By about age 16, teens diagnosed with depression have substantially lower educational attainment, a new British study finds. Targeted educational support might be of particular benefit to teens from poor backgrounds and boys, but all children with depression can benefit from such help, the study authors suggested. For the study, the researchers used British health and education records to identify nearly 1,500 kids under 18 years of age with depression. Typically, their depression was diagnosed around age 15. Their educational attainment was compared with a group of young people who were not depressed. Among students with a diagnosis of depression, 83% reached expected educational attainment at ages 6 to 7, but only 45% hit more...

THURSDAY, Oct. 8, 2020 (American Heart Association News) -- LGBTQ adults face distinct threats to their heart health – and health care providers can do more to identify and thwart those risks, says a new report that aims to point the way toward better research and care. The report, issued Thursday as a scientific statement from the American Heart Association, pulls together what scientists have learned about LGBTQ health, highlighting known problems and identifying gaps, said Dr. Nicole Rosendale, a member of the committee that wrote the report. It aims to serve as a "one-stop shop" for heart health findings on a group that in the past has been "largely invisible within health care research and studies," said Rosendale, an assistant professor of neurology at the University of...

THURSDAY, Oct. 8, 2020 (HealthDay News) -- Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19. Hours before the company made the announcement, Trump proclaimed in a video released by the White House that the drug had an "unbelievable" effect on his recovery from coronavirus infection, the Washington Post reported. "I think this was the key," Trump said, after acknowledging that the antibody cocktail was one of several drugs he was prescribed by his medical team. While there is no hard evidence yet proving the drug's effectiveness in humans, it has shown promise in treating mild cases of the new...